Avance Life sciences in Lithuania
Life Sciences
Life Sciences

Boutique Life Sciences advisory Avance opens office in Vilnius

February 20, 2024

Avance Life Sciences, a Swiss advisory firm focused on the Life Sciences industry, has recently opened an office in Vilnius. In Lithuania, Avance expects to build a team of highly specialized, interdisciplinary specialists providing financial advisory services and supporting the company’s valuation and licensing modeling platform. 

Headquartered in Switzerland, Avance provides services to Biotech and Pharma companies, universities, and investors in the Life Sciences space. The company counts such well-known names as Roche, AbbVie, and Bayer among its broad client base in the US, Germany, the UK, Switzerland, and elsewhere.  

Vilnius is Avance’s third office, after headquarters in Basel and an office in Rotterdam, the Netherlands. The company’s Lithuania team will support financial advisory activities and the adoption of RIVAL, Avance’s recently launched global platform. RIVAL allows Biotech and Pharma companies to simplify the valuation of their pipeline and optimize their licensing deals. 

According to Cees de Wit, Director at Avance Life Sciences, the skill and ambition of Lithuanian talent were among the main factors behind the decision to set up an office in Vilnius: 

In Lithuania, we see a good fit with our Swiss work culture. The international outlook and solid English language levels of the people are an asset. Furthermore, the country's focus on high-tech industries was part of the reasons to select Lithuania as our new location.
Cees de Wit, Director at Avance Life Sciences

Avance is seeking ambitious professionals with a background in Finance, Life Sciences, and SaaS sales. 

“We have only recently established our company in Vilnius but are very happy with the talent we have been able to attract so far,” says Cees de Wit. “We see continued growth for our Lithuanian business as part of our overall company growth strategy.” 

Elijus Čivilis, General Manager at Invest Lithuania, sees Avance as an incredibly valuable addition to the country’s Life Sciences landscape: 

Avance brings expertise in financial advisory, licensing, and valuation services for pharmaceutical, biotechnology, medical technology, and digital health companies. This will strengthen our Life Sciences sector with competencies that help commercialize technologies and innovation as well as create jobs for highly specialized, interdisciplinary talent.
Elijus Čivilis, General Manager at Invest Lithuania

As a result of a decade’s worth of fast-paced growth, the Life Sciences industry currently generates around 2.5% of Lithuania’s GDP. Lithuania hopes to maintain this momentum – Life Sciences is among the country’s priority economic sectors, receiving considerable attention from governmental institutions. This support is boosted by an integrated network of science valleys and educational institutions that supply businesses with a pool of top-notch talent that is eager to learn. 

Subscribe CTA image

Enjoy reading our news?

Please wait...

Thank you for subscribing to our newsletter!

Have questions? Contact us
Aistė Žebrauskienė
Press Officer LinkedIn icon
Contact me
Get in touch

    Aistė Žebrauskienė Press Officer
    Thank you!

    Thanks for reaching out to us, this means a lot! We will get back to you shortly.

    Meanwhile, we invite you to discover what’s new in the Lithuanian business landscape.

    Vilnius panorama